Studies in porphyria IX: Detection of the gene defect of erythropoietic protoporphyria in mitogen-stimulated human lymphocytes.
We have demonstrated in this study that mitogen-stimulated lymphocytes from EPP subjects accumulate substantially greater amounts of protoporphyrin IX than do normal lymphocytes when incubated with ALA. Protoporphyrin IX formation by normal lymphocytes is stimulated by CaMgEDTA, an inhibitor of ferrochelatase, and is decreased by ferrous iron which facilitates the utilization of protoporphyrin IX for heme synthesis. In contrast, protoporphyrin IX formation by EPP lymphocytes is less stimulated by CaMgEDTA than is the case with normal lymphocytes and is only slightly affected by iron. Clinically manifested EPP subjects and completely latent gene carriers of EPP can be identified using this lymphocyte culture technique. The data from this study provide clear evidence of a functional deficiency of ferrochelatase activity in human EPP lymphocytes. EPP thus represents the third of the three dominant porphyric disorders of man, including acute intermittent porphyria and hereditary coproporphyria, which can now be diagnosed using lymphocytes.
D000293:Adolescent; D000328:Adult; D000622:Aminolevulinic Acid / Q000378:metabolism; D002478:Cells, Cultured; D005260:Female; D006579:Heterozygote; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D011164:Porphyrias / Q000175:diagnosis / Q000235:genetics / Q000276:immunology*; D046351:Protoporphyria, Erythropoietic; D011524:Protoporphyrins / Q000096:biosynthesis / Q000378:metabolism
D011524:Protoporphyrins; D000622:Aminolevulinic Acid